Category - Next generation sequencing

Base Genomics announces company launch and raises $11 million USD to commercialize epigenetic technology for early and sensitive detection of cancer from liquid biopsy

Epigenetics company Base Genomics launches, based on a new invention to sequence DNA methylation developed at the Ludwig Institute for Cancer Research Branch at the University of Oxford The technology, TAPS (TET...read more

QIAGEN launches new solution, QCI Interpret One, which combines QIAGEN Clinical Insights solutions with trusted N-of-One services to deliver gold-standard interpretation of somatic variants in cancer patients

Hilden, Germany, and Germantown, Maryland, May 28, 2020 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of novel solutions enabling faster, better analysis of genomic variations...read more

Ginkgo Bioworks to Build Infrastructure for Rapid Epidemic Response with $70MM Investment

Strategic investment from Illumina and others enables large-scale COVID-19 testing using next generation sequencing BOSTON, May 28, 2020 /PRNewswire/ — Today, Ginkgo Bioworks is announcing...read more

Roche acquires Stratos Genomics to further develop DNA based sequencing for diagnostic use

TruGenomix Partners with BlueBee to Create the Next Generation Behavioral Science Data Ecosystem

ROCKVILLE, Maryland and SAN MATEO, California, May 20, 2020 /PRNewswire/ — The unprecedented COVID-19 crisis has unleashed global emotional trauma that is rapidly evolving into a mental health...read more

New partnership to sequence human genomes in the fight against coronavirus

The Role of the Human Gut Microbiome in Type 1 Diabetes

Regeneron And Colorado Center For Personalized Medicine Announce Major New Human Genetics Research Collaboration

GRAIL Announces $390 Million Series D Financing

Lifebit Closes $7.5M Series A Round to Accelerate Global Market Expansion

Industry News

An interview with Michael Snyder, Stanford W. Ascherman Professor and Chair, Department of Genetics & Director, Center for Genomics and Personalized Medicine

Nebion Provides Curated Omics Data Combined with Innovative Visualizations for Target Discovery, Indication Finding, and Drug Safety Assessment

Sentieon Solves Complex Mathematical Problems – Applied to DNA Sequence Secondary Data Analysis – by Enhancing them With Extreme Accuracy and Efficiency

AGBT 2019, And the Winners are “Spatial Genomics, Single-cell Genomics, and Long-read Sequencing”

Blueprint Genetics Aims to Automate and Improve Clinical Interpretation Processes with Software That Will Change the Industry

Review of Emerging 2018 Genomic Variants – a Genomenon Research Report

%d bloggers like this:

Category - Next generation sequencing

Base Genomics announces company launch and raises $11 million USD to commercialize epigenetic technology for early and sensitive detection of cancer from liquid biopsy

QIAGEN launches new solution, QCI Interpret One, which combines QIAGEN Clinical Insights solutions with trusted N-of-One services to deliver gold-standard interpretation of somatic variants in cancer patients

Ginkgo Bioworks to Build Infrastructure for Rapid Epidemic Response with $70MM Investment

Roche acquires Stratos Genomics to further develop DNA based sequencing for diagnostic use

TruGenomix Partners with BlueBee to Create the Next Generation Behavioral Science Data Ecosystem

New partnership to sequence human genomes in the fight against coronavirus

Regeneron And Colorado Center For Personalized Medicine Announce Major New Human Genetics Research Collaboration

GRAIL Announces $390 Million Series D Financing

Industry News

An interview with Michael Snyder, Stanford W. Ascherman Professor and Chair, Department of Genetics & Director, Center for Genomics and Personalized Medicine

Nebion Provides Curated Omics Data Combined with Innovative Visualizations for Target Discovery, Indication Finding, and Drug Safety Assessment

Othram Aims to Overcome DNA Sequencing Challenges to Solve Forensic Crime Cases

AGBT 2019, And the Winners are “Spatial Genomics, Single-cell Genomics, and Long-read Sequencing”

Blueprint Genetics Aims to Automate and Improve Clinical Interpretation Processes with Software That Will Change the Industry

Review of Emerging 2018 Genomic Variants – a Genomenon Research Report

Follow Me

Most popular

Base Genomics announces company launch and raises $11 million USD to commercialize epigenetic technology for early and sensitive detection of cancer from liquid biopsy

QIAGEN launches new solution, QCI Interpret One, which combines QIAGEN Clinical Insights solutions with trusted N-of-One services to deliver gold-standard interpretation of somatic variants in cancer patients

Ginkgo Bioworks to Build Infrastructure for Rapid Epidemic Response with $70MM Investment

Roche acquires Stratos Genomics to further develop DNA based sequencing for diagnostic use

Nautilus Biotechnology Raises $76 Million in Series B Funding to Be the First to Quantify the Human Proteome

TruGenomix Partners with BlueBee to Create the Next Generation Behavioral Science Data Ecosystem

New partnership to sequence human genomes in the fight against coronavirus

Regeneron And Colorado Center For Personalized Medicine Announce Major New Human Genetics Research Collaboration

GRAIL Announces $390 Million Series D Financing

Most discussed

The JP Morgan Healthcare Conference from Afar

Genomenon’s Automated Genomic Search Engine Mastermind Illuminates Current Trends in Genomic Literature – A Look at the Top Cited Variants Across the Scientific Literature

The Life of a Genetic Counselor: Providing Patient Education, Navigating Insurance, and Challenges in Choosing Tests

Nebula Genomics’ Goal Is To Make The Value of Genome Sequencing a Reality

Genohm Aims to Hit the Sweet Spot With a Customizable SLIMS + ELN Solution for Lab Information Management

Just Released – Our New Clinical NGS Process Report

PMWC 2016 Silicon Valley: Scalable Clinical Data Interpretation The Biggest Bottleneck

enlightenbio Customer Spotlight: Cypher Genomics Clinical Content Curation

ACMG 2014 headlines included rethinking diagnostics, incidental findings, & variant interpretation

Base Genomics announces company launch and raises $11 million USD to commercialize epigenetic technology for early and sensitive detection of cancer from liquid biopsy